Akèy › Sipwa › Alabama › Mobile

Etid klinik pou Sipwa nan Mobile, AL

5 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote Mobile (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Ap rekriteFaz 2

AMR Clinical - Mobile, Mobile

Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07685808

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Ap rekriteFaz 3

Mobile Heart Specialists PC, Mobile
Alliance For Multispecialty Research - Daphne, Daphne · 10 mi lwen
Eastern Shore Research Institute, Fairhope · 14 mi lwen

Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Ap rekriteFaz 3

AMR Clinical, Mobile

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07353931

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Ap rekriteFaz 3

Research Site, Mobile
Research Site, Fairhope · 14 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Ap rekriteFaz 3

Alliance for Multispecialty Research Mobile, Mobile
Alliance For Multispecialty Research - Daphne, Daphne · 10 mi lwen

Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684235

Etid Sipwa nan lòt vil

Lòt etid nan Mobile

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.